HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sevoflurane inhibits angiotensin II-induced Rho kinase-mediated contraction of vascular smooth muscle from spontaneously hypertensive rat.

AbstractPURPOSE:
Angiotensin II (Ang II)-induced vasoconstriction is mediated by changes in intracellular free Ca(2+) concentration ([Ca(2+)](i)) and myofilament Ca(2+) sensitivity. Protein kinase C- and Rho kinase-mediated signaling pathways are proposed for the regulation of the Ca(2+) sensitization mechanisms. We have demonstrated that sevoflurane inhibits Rho kinase-mediated contraction of isolated rat aortic smooth muscle. A recent study demonstrated that Rho-kinase mediated Ca(2+) sensitization was involved in the pathophysiology of hypertension. This study was designed to investigate the effects of sevoflurane on Ang II-induced Rho kinase-mediated vascular contraction in spontaneously hypertensive rats (SHR).
METHODS:
The effects of sevoflurane on vasoconstriction, increase in [Ca(2+)](i), and membrane translocation of Rho kinase in response to Ang II were investigated in normotensive Wistar-Kyoto rats (WKY) and SHR, using an isometric force transducer, a fluorometer, and Western blotting, respectively.
RESULTS:
The inhibitory effects of sevoflurane on Ang II (10(-7)M)-induced contraction were greater (P < 0.05) in SHR than in WKY at the highest concentration of sevoflurane (5.1%). Y27632 (3 × 10(-7)M), a specific inhibitor of Rho kinase, inhibited the Ang II-induced contraction in SHR, but not in WKY. Sevoflurane did not affect the increases in [Ca(2+)](i) in response to Ang II in either strain. Ang II stimulated Rho kinase activity in SHR, which was almost abolished by sevoflurane at a concentration of 5.1% (P < 0.05).
CONCLUSIONS:
These findings suggest that the inhibition of the Ang II-induced contraction by sevoflurane in SHR may be, at least in part, due to the attenuation of the Rho kinase-mediated signaling pathway.
AuthorsNobuhiko Uematsu, Koji Ogawa, Yasuyuki Tokinaga, Kazuaki Tange, Yoshio Hatano
JournalJournal of anesthesia (J Anesth) Vol. 25 Issue 3 Pg. 398-404 (Jun 2011) ISSN: 1438-8359 [Electronic] Japan
PMID21409351 (Publication Type: Journal Article)
Chemical References
  • Amides
  • Anesthetics, Inhalation
  • Enzyme Inhibitors
  • Methyl Ethers
  • Pyridines
  • Angiotensin II
  • Y 27632
  • Sevoflurane
  • rho-Associated Kinases
  • Calcium
Topics
  • Amides (pharmacology)
  • Anesthetics, Inhalation (pharmacology)
  • Angiotensin II (antagonists & inhibitors, pharmacology)
  • Animals
  • Aorta, Thoracic (drug effects)
  • Blood Pressure (drug effects)
  • Calcium (metabolism)
  • Calcium Signaling (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • In Vitro Techniques
  • Isometric Contraction (drug effects)
  • Male
  • Methyl Ethers (pharmacology)
  • Muscle Contraction (drug effects)
  • Muscle, Smooth, Vascular (drug effects)
  • Protein Transport
  • Pyridines (pharmacology)
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Sevoflurane
  • rho-Associated Kinases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: